Investigating new treatments for ovarian cancer
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
This study is exploring new treatments for ovarian cancer that can work better for patients who haven't responded well to standard therapies, and it's designed for all women facing this challenge, especially those from different backgrounds.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10931353 on NIH RePORTER |
What this research studies
This research focuses on developing and testing innovative therapies for ovarian cancer, particularly those that can overcome resistance to existing treatments like chemotherapy and targeted therapies. The team at MD Anderson Cancer Center is working on strategies involving anti-angiogenic agents and immune checkpoint inhibitors, aiming to improve patient outcomes. They have a strong commitment to including diverse patient populations in their research, ensuring that findings are applicable to a wide range of individuals affected by ovarian cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with ovarian cancer, particularly those who have not responded well to standard treatments.
Not a fit: Patients with non-ovarian cancers or those who are not currently undergoing treatment for ovarian cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for ovarian cancer patients, potentially improving survival rates and quality of life.
How similar studies have performed: Previous research has shown promise in similar therapeutic approaches for ovarian cancer, indicating a potential for significant advancements in treatment.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Sood, Anil K — University of Tx Md Anderson Can Ctr
- Study coordinator: Sood, Anil K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.